Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
852 studies found for:    "Cystic fibrosis"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed Cystic Fibrosis Withdrawal of Inhaled Steroids Evaluation Study (CF WISE Study)
Condition: Cystic Fibrosis
Intervention: Drug: Fluticasone or placebo
2 Recruiting Integrating Supportive Care in Cystic Fibrosis
Condition: Cystic Fibrosis
Intervention: Behavioral: Supportive Care Intervention
3 Completed Pharmacokinetic Study of Lansoprazole in Cystic Fibrosis
Condition: Cystic Fibrosis
Intervention: Drug: Lansoprazole
4 Completed The Role of Respiratory Viruses in Exacerbations of Cystic Fibrosis in Adults
Condition: Cystic Fibrosis
Intervention:
5 Unknown  RhDNase and Biodistribution of PMN Serine Proteases in Cystic Fibrosis Sputum
Condition: Cystic Fibrosis
Intervention: Drug: Pulmozyme
6 Completed Safety Study of Inhaled 552-02 in Cystic Fibrosis Patients
Condition: Cystic Fibrosis
Intervention: Drug: 552-02
7 Completed 28 Day Repeat Dose in Cystic Fibrosis Patients
Condition: Cystic Fibrosis
Interventions: Drug: SB656933;   Drug: Placebo
8 Completed 18FDG- PET/CT Contribution to the Assessment of Lesion Severity in Cystic Fibrosis (CF)
Condition: Cystic Fibrosis
Intervention: Procedure: PET-CT
9 Completed Comparison of Inhaled Mannitol and rhDNase in Children With Cystic Fibrosis
Condition: Cystic Fibrosis
Interventions: Drug: mannitol;   Drug: mannitol + pulmozyme;   Drug: Dornase alpha
10 Not yet recruiting Registry Study on Cystic Fibrosis in Chinese Children
Condition: Cystic Fibrosis
Intervention:
11 Completed A Study of the Safety and Efficacy of Tobramycin for Inhalation in Young Children With Cystic Fibrosis
Condition: Cystic Fibrosis
Intervention: Drug: Tobramycin for Inhalation
12 Completed An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Condition: Cystic Fibrosis
Interventions: Other: Ophthalmologic examinations;   Drug: Ivacaftor Exposed
13 Completed Inhaled Bicarbonate Therapy in Cystic Fibrosis
Condition: Cystic Fibrosis
Intervention: Procedure: sodium bicarbonate
14 Recruiting Observational Study of Outcomes in Cystic Fibrosis Patients With Selected Gating Mutations on a CFTR Allele (The VOCAL Study)
Condition: Cystic Fibrosis
Intervention: Drug: ivacaftor
15 Completed
Has Results
Study of Ivacaftor in Cystic Fibrosis Subjects 2 Through 5 Years of Age With a CFTR Gating Mutation
Condition: Cystic Fibrosis
Intervention: Drug: Ivacaftor
16 Completed Impact of Global Care of the Pain at Chronic Painful Patients Affected by Cystic Fibrosis
Condition: Cystic Fibrosis
Intervention: Other: sophrology sessions at home
17 Completed
Has Results
A Phase II , Placebo-controlled Study to Assess Efficacy of 28 Day Oral AZD9668 in Patients With Cystic Fibrosis
Condition: Cystic Fibrosis
Interventions: Drug: AZD9668;   Drug: AZD9668 Placebo equivalent
18 Completed Tolerability of Inhaled Hypertonic Saline in Infants With Cystic Fibrosis
Condition: Cystic Fibrosis
Intervention: Drug: inhaled 7% hypertonic saline (HS)
19 Completed Trial of Doxycycline to Reduce Sputum MMP-9 Activity in Adult Cystic Fibrosis (CF) Patients
Condition: Cystic Fibrosis
Interventions: Drug: Doxycycline;   Other: placebo
20 Completed Roll-Over Study of Ivacaftor in Cystic Fibrosis Pediatric Subjects With a CF Transmembrane Conductance Regulator Gene (CFTR) Gating Mutation
Condition: Cystic Fibrosis
Intervention: Drug: Ivacaftor

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.